WHO ICTRP trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the…
EUCTR2021-001447-27-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2021-001447-27-DE |
|---|---|
| Public title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Adult Subjects with Generalized Pustular Psoriasis |
| Scientific title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Adult Subjects with Generalized Pustular Psoriasis - Efficacy and Safety of Imsidolimab in Subjects with Generalized Pustular Psoriasis |
| Primary sponsor | AnaptysBio Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Romania;United States;Taiwan;Korea, Republic of;Poland;Malaysia;Georgia;Australia;Thailand;France;Germany;Spain |
| Conditions | Subjects with generalized pustular psoriasis MedDRA version: 20.0 Level: PT Classification code 10037575 Term: Pustular psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin… |
| Interventions | Product Code: ANB019 Pharmaceutical Form: Solution for infusion INN or Proposed INN: anti-IL-36R monoclonal antibody Current Sponsor code: ANB019 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration… |
| Registration date | Aug 9, 2021 |
| Target size | 45 |
| Secondary IDs | ANB019-301 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: